CMS certification 240080
M Health Fairview University of Mn Medical Center
2450 Riverside Avenue, Minneapolis, MN 55454
M Health Fairview University of Mn Medical Center has a CMS overall rating of 4 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on none. Emergency patients spend a median of 2 h 54 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 405 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MN | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 355 visits sampled · US median for EDs of the same volume: 3 h 22 min | 2 h 54 min | 2 h 11 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 50 visits sampled | 5 h 18 min | 3 h 24 min | 4 h 17 min |
| Left before being seen Lower is better · 52,842 patients | 2% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 85 patients | 73% | 58% | 65% |
How M Health Fairview University of Mn Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| M Health Fairview University of Mn Medical CenterThis hospital | 4/5 | 69% | 2 h 54 min | 3 better |
| Minneapolis VA Medical CenterSame city | 5/5 | 81% | — | 5 better 2 worse |
| Hennepin County Medical CenterSame city | 3/5 | 63% | 3 h 55 min | 3 better |
| Abbott Northwestern HospitalSame city | 4/5 | 72% | 3 h 3 min | 2 better 1 worse |
| M Health Fairview Southdale HospitalSame county · Edina | 5/5 | 71% | 3 h 24 min | 8 better |
| Park Nicollet Methodist HospitalSame county · Saint Louis Park | 3/5 | 81% | 4 h 17 min | 3 better 3 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Minneapolis.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 2,958 cases | Too few cases | 2.5% | 3.9% |
| Heart attack 44 cases | Too few cases | 11.9% | 11.9% |
| Heart failure 190 cases | Too few cases | 8.9% | 11.1% |
| Pneumonia 181 cases | Too few cases | 12.1% | 15.2% |
| Stroke 177 cases | Too few cases | 10% | 11.9% |
| COPD 27 cases | Too few cases | 8.1% | 8.6% |
| Heart bypass surgery (CABG) 66 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.85 likely 0.64 – 1.06 | 1 |
| After hip or knee replacement 87 cases | Too few cases | 6.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 247 cases | No different | 198.81 per 1,000 likely 161.42 per 1,000 – 236.2 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,733 cases | Better | 0.16 per 1,000 likely 0 per 1,000 – 0.61 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 6,968 cases | No different | 0.14 per 1,000 likely 0 per 1,000 – 0.34 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 7,891 cases | No different | 0.32 per 1,000 likely 0.14 per 1,000 – 0.51 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,587 cases | No different | 1.72 per 1,000 likely 0.41 per 1,000 – 3.03 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,474 cases | No different | 2.01 per 1,000 likely 0.8 per 1,000 – 3.22 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,468 cases | No different | 8.36 per 1,000 likely 4.84 per 1,000 – 11.88 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,510 cases | No different | 4.8 per 1,000 likely 3.15 per 1,000 – 6.45 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,546 cases | No different | 4.34 per 1,000 likely 2.11 per 1,000 – 6.57 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 820 cases | No different | 1.6 per 1,000 likely 0.27 per 1,000 – 2.94 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,072 cases | No different | 0.75 per 1,000 likely 0 per 1,000 – 1.57 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.94 likely 0.71 – 1.23 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.66 likely 0.4 – 1.03 | 1 |
| Surgical site infections after colon surgery | No different | 0.94 likely 0.48 – 1.68 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.92 likely 0.24 – 2.51 | 1 |
| MRSA bloodstream infections | Better | 0.56 likely 0.28 – 1 | 1 |
| C. diff intestinal infections | Better | 0.43 likely 0.31 – 0.57 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 101 cases | Too few cases | 15.3% | 14.4% |
| Readmitted after heart failure 420 cases | Too few cases | 19.5% | 21.3% |
| Readmitted after pneumonia 397 cases | Too few cases | 17.9% | 17.3% |
| Readmitted after COPD 93 cases | Too few cases | 20.5% | 20% |
| Readmitted after heart bypass surgery 62 cases | Too few cases | 11.8% | 11% |
| Readmitted after hip or knee replacement 98 cases | Too few cases | 5.8% | 5.8% |
| Days back in hospital after a heart attack 62 cases | Too few cases | -32.5 days per 100 | — |
| Days back in hospital after heart failure 240 cases | Too few cases | -7.6 days per 100 | — |
| Days back in hospital after pneumonia 179 cases | Too few cases | 63.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 321 cases | No different | 14 per 1,000 likely 10.6 per 1,000 – 18.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 707 cases | Worse | 13.9 per 100 likely 11.6 per 100 – 16.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 707 cases | Worse | 7.3 per 100 likely 5.7 per 100 – 9.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 322 cases | No different | 1.1 likely 0.9 – 1.4 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
1,312 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 205 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Occupational Therapist | 144 |
| Physical Therapist | 122 |
| Pediatrics | 83 |
| Nurse Anesthetist, Certified Registered | 63 |
| Internal Medicine | 62 |
| Clinical | 54 |
| Speech-Language Pathologist | 53 |
| Physician Assistant | 43 |
| Psychiatry | 42 |
| Rehabilitation Practitioner | 42 |
| Dietitian, Registered | 38 |
| Emergency Medicine | 37 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.2M
- 2020 $884,235
- 2021 $634,236
- 2022 $339,435
- 2023 $981,288
- 2024 $1M
- 2025 $2.7M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $193,784 | 36 |
| Medical devices and supplies on long-term loan | $131,677 | 23 |
| Speaking, teaching and other services | $95,040 | 12 |
| Grants | $14,000 | 3 |
| Education | $8,500 | 4 |
| Gifts | $740 | 1 |
| Debt forgiveness | $182 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie INC. | $813,882 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $670,992 | 50 |
| Amgen Inc. | $168,642 | 3 |
| Janssen Research & Development, LLC | $168,364 | 20 |
| Transmedics, INC. | $135,901 | 18 |
| Boston Scientific Corporation | $114,937 | 35 |
| Abbott Laboratories | $104,703 | 8 |
| AstraZeneca Pharmaceuticals LP | $94,825 | 4 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A randomized phase II trial of Mirvetuximab soravtansine (IMGN853), in BRCA wild-type, folate receptor alpha (FR)-positive recurrent ovarian cancer e… ABBVIE INC. | $610,412 |
| A PHASE 1/2, FIRST-IN-HUMAN, OPEN LABEL, DOSE ESCALATION STUDY OF MVC-101, AN EGFR X CD3 CONDITIONAL BISPECIFIC REDIRECTED ACTIVATION (COBRATM) PROTE… Takeda Pharmaceuticals U.S.A., Inc. | $343,921 |
| TAK-280-1501 Takeda Pharmaceuticals U.S.A., Inc. | $220,206 |
| Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients receiving Neoadjuvant Chemotherapy with Ad… ABBVIE INC. | $203,471 |
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral … Janssen Research & Development, LLC | $160,034 |
| OLP-II TRANSMEDICS, INC. | $90,968 |
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants Wi… Amgen Inc. | $90,767 |
| A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failur… AstraZeneca Pharmaceuticals LP | $89,825 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about M Health Fairview University of Mn Medical Center
Is M Health Fairview University of Mn Medical Center a good hospital?
M Health Fairview University of Mn Medical Center has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend M Health Fairview University of Mn Medical Center?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 405 completed HCAHPS surveys.
How long is the wait in the M Health Fairview University of Mn Medical Center emergency room?
Emergency patients spend a median of 2 h 54 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does M Health Fairview University of Mn Medical Center receive money from drug and device companies?
Drug and device makers reported $2.7M in payments to M Health Fairview University of Mn Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.